Who Paid My Doc
Phil
Device Neurological Product
General payments
$83,283
Research payments
$507,241
Through program year 2025, $83,283 in general payments and $507,241 in research payments were reported against Phil (Neurological Product).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
11 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $14,534 | 25 |
| 2025 | Research | $2,175 | 2 |
| 2024 | General | $2,009 | 8 |
| 2024 | Research | $26,390 | 10 |
| 2023 | General | $21,859 | 25 |
| 2023 | Research | $110,862 | 16 |
| 2022 | General | $517 | 4 |
| 2020 | General | $19,418 | 27 |
| 2020 | Research | $201,285 | 31 |
| 2019 | General | $24,947 | 124 |
| 2019 | Research | $166,530 | 45 |
Breakdown
The top 5 of 15 recipients; each share is of general payments naming this product in 2025.
The top 5 of 6 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 8 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
213 general · 104 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.